Heteroaggregation of Antimicrobial Peptides LL-37 and HNP1 Drives Cooperative Neutralization of Cytotoxicity

Jing Zhang1, Yuge Hou1,2, Takashi Yasuda3

  • 1Institute of Industrial Science, The University of Tokyo, 4-6-1 Komaba Meguro-Ku, Tokyo 153-8505, Japan.

JACS Au
|March 27, 2026
PubMed

Insights

Antimicrobial peptides (AMPs) like LL-37 and HNP-1 can reduce host-cell toxicity when they aggregate. This aggregation state is key to their function, impacting both cell death and survival pathways.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Antimicrobial peptides (AMPs) are crucial for innate immunity.
  • Synergistic effects of AMPs on bacterial killing are well-documented.
  • The impact of AMPs on host-cell cytotoxicity and the role of aggregation are less understood.

Purpose of the Study:

  • To investigate how heteroaggregation of human cathelicidin (LL-37) and human α-defensin-1 (HNP-1) affects host-cell cytotoxicity.
  • To determine the specific stoichiometric ratios governing the cooperative effects of LL-37 and HNP-1.
  • To elucidate the mechanisms underlying the modulation of cytotoxicity by AMP heteroaggregation.

Main Methods:

  • Dynamic light scattering (DLS) for aggregation analysis.
  • MTT assays and live/dead staining for cytotoxicity assessment.
  • Fluo-3 calcium imaging, apoptosis/necrosis assays, and ROS detection.
  • Optical and atomic force microscopy for structural visualization.

Main Results:

  • Cooperative reduction of MDCK-I cell cytotoxicity by LL-37 and HNP-1 occurs at a specific stoichiometric ratio (approx. 0.025 HNP-1 to LL-37).
  • Mutual antagonism between LL-37 and HNP-1 was observed, modulating cell death pathways.
  • HNP-1 suppressed LL-37-induced necrosis, while LL-37 reduced HNP-1-induced apoptosis.

Conclusions:

  • Heteroaggregation state is a critical determinant of AMPs' structure-function relationship.
  • AMP aggregation influences their ability to reduce host-cell cytotoxicity.
  • Understanding AMP aggregation provides insights into their dual role in host defense and potential toxicity.

Related Concept Videos

Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
3.8K
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
15.4K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
10.4K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.8K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.4K
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
124